The World Health Organization (WHO) is deeply concerned about the consequences of the immediate cessation of funding for HIV programs in low and medium -income countries. These programs provide access to HIV therapy that has saved from life to more than 30 million people worldwide. Worldwide, 39.9 million people lived with HIV in late 2023.
A funding for HIV programs can put people living with HIV with an immediate increased risk of illness and death and undermine efforts to prevent transmission in communities and countries. Such measures, if prolonged, could lead to increases in new infections and deaths, reversing decades of progress and possibly take the world back in the 1980s and 1990s, when millions died from HIV each year, including, including Many in the United States of America.
For the global community, this could lead to significant failures in the progress of corporate relations and investment in scientific advances that have been the cornerstone of good public health planning, including innovative diagnostic, affordable drugs and HIV community care models.
We call on the United States government to allow additional exemptions to ensure the delivery of HIV treatment and care.
The legacy and current Pepfar risks
The President of the United States for Relief AIDS (Pepfar) is an Emergency Emergency Plan for the flagship initiative of HIV’s global reaction since its founding 20 years ago. The current funding for Pepfar will have a direct impact on millions of lives depending on the predictable offer of safe and effective antiretroviral therapy.
Pepfar works in more than 50 countries around the world. In the last two decades, Pepfar funding has saved more than 26 million lives. Currently, Pepfar provides HIV treatment for more than 20 million people living with HIV worldwide, including 566 000 children under 15 years.
In the past year, Pepfar and partners, including, working in viability plans with countries for larger country and reduced donor support by up to 2030. A sudden and prolonged stance on programs does not allow management and management and the transition is the lives of millions at risk.
Who is committed to supporting Pepfar and other partners, as well as national governments, managing change processes effectively to minimize impact on people living with HIV.
